Speaker Name: 
"PD-L1 Status as a Biomarker in NSCLC: What the numbers really tell us" Barry Paul, MD 2nd Year Hem Onc Fellow “Radiotherapy for Oligometastases” Joseph Salama, MD Associate Professor Residency Program Director Department of Radiation Oncology Duke Unive
143 Jones Bldg
Durham, NC 27701
United States
Room Number: 
143 Jones Bldg
Session date: 
Wednesday, December 6, 2017 - 7:30am to 9:00am
  • 1.50 AMA PRA Category 1 Credit(s)
  • 1.50 Attendance

Please login or register to take this course.